CONTACTS 

SUBJECTS
Meeting Doctor Assess Treatment Review Progress Substantially Rising

0403 -
0403 -    ..
0404 - Summary/Objective
0405 -
040501 - Follow up ref SDS 58 0000. ref SDS 53 0000.
040502 -
040503 - CA 15-3 jumped significantly again this cycle to over 100, possibly
040504 - due to missed treatments that reduced concentration of AC; signals
040505 - need for action. ref SDS 0 GJ5M  CT test results were not available,
040506 - but expected to continue showing no distant metastasis, even though
040507 - IBC is advancing. ref SDS 0 NL4N  MUGA test was not avilable for the
040508 - meeting; since AC treatment was stopped today, this is not
040509 - significant. ref SDS 0 IL7F  Biopsy wound shows healing, but IBC has
040510 - not significantly improved under treatment with AC. ref SDS 0 025H
040511 - Surgeon's examination and comments were reviewed indicating that
040512 - mastectomy requires clearing the left breast of disease prior to
040513 - surgery. ref SDS 0 XQ41  Treatment was changed from AC to Taxotere and
040514 - capecitabine (Xeloda). ref SDS 0 T58M
040515 -
040516 -            [On 050502 visual improvement sores and inflamation are
040517 -            receding, ref SDS 69 EO5J
040519 -             ..
040520 -            [On 050510 further improvement inflammation (redness) seems
040521 -            entirely gone, and softness has returned to the breast.
040522 -            ref SDS 70 EO5J
040524 -             ..
040525 -            [On 050520 dramatic improvement after 2 cycles of treatment
040526 -            with Taxotere and Xeloda. ref SDS 73 R19I
040527 -
040528 -
040529 -
040530 -
040532 -  ..
0406 -
0407 -
0408 - Discussion
0409 -
040901 - Agenda for Work Plan After 2 Treatments of AC
040902 -
040903 - Follow up ref SDS 58 SM6M, ref SDS 53 SM6M.
040905 -  ..
040906 - Millie created an agenda on the marking board...
040907 -
040908 -        CA 15-3 dramatic rise...................... ref SDS 0 GJ5M
040909 -        CT test results............................ ref SDS 0 NL4N
040910 -        MUGA test results to continue AC........... ref SDS 0 IL7F
040911 -        Wound punch biopsy better.................. ref SDS 0 6T5G
040912 -        Breast exam worsening IBC.................. ref SDS 0 025H
040913 -        Surgeron examination report................ ref SDS 0 XQ41
040914 -        Treatment plan............................. ref SDS 0 AW5G
040915 -
040916 -
040917 -
040918 -
040919 -
0410 -

SUBJECTS
CA 15-3 100 Down from 105 Substantially Up from 88 in 3 Weeks Aligns

1203 -
120401 -  ..
120402 - CA 15-3 Cancer Marker 100 Rises Dramatically to Dangerous Level
120403 -
120404 - Follow up ref SDS 58 087J, ref SDS 53 087J.
120405 -
120406 - Blood test on 050325 shows CA 15-3 dropped to 100 from the prior test
120407 - on 050318 which increased to 101 from 88 reported on 050325,
120408 - ref SDS 63 2N5J, continuing a rise from 95 reported three (3) weeks
120409 - ago on 050308, and cited a few days later during the meeting on
120410 - 050311. ref SDS 58 087J
120412 -           ..
120413 -          050325.........100 H............. 050329, ref SDS 0 087J
120414 -          050318.........101 H............. 050325, ref SDS 63 2N5J
120415 -          050304......... 88 H............. 050311, ref SDS 58 087J
120416 -          050225......... 95 H............. 050308, ref SDS 57 0001
120417 -          050211......... 78 H............. 050214, ref SDS 55 02BB
120418 -          050128......... 67 H............. 050204, ref SDS 53 087J
120419 -          041228......... 56 H............. 041230, ref SDS 48 087J
120420 -          041204......... 43 H............. 041210, ref SDS 45 087J
120421 -          041007......... 39............... 041104, ref SDS 38 087J
120422 -          040923......... 49 H............. 041005, ref SDS 36 087J
120423 -          040908......... 44 H............. 040909, ref SDS 35 087J
120424 -          040825......... 47 H............. 040812, ref SDS 35 087J
120425 -          040811......... 42 H............. 040812, ref SDS 34 087J
120426 -          040728......... 43 H............. 040729, ref SDS 33 2N5J
120427 -          040712......... 47 H............. 040713, ref SDS 32 087J
120428 -          040614......... 55 H............. 040615, ref SDS 31 PX6X
120429 -          040517......... 78 H............. 040601, ref SDS 30 2N5J
120430 -          040311......... 70 H............. 040318, ref SDS 27 SM6M
120431 -          040205......... 60 H............. 040211, ref SDS 26 SM6M
120432 -          031201......... 62 H............. 031205, ref SDS 25 SM6M
120433 -          030912......... 66 H............. 030915, ref SDS 24 SM6M
120434 -          030708......... 68 H............. 030710, ref SDS 23 SM6M
120435 -          030503......... 54 H............. 030508, ref SDS 21 SM6M
120436 -          030403......... 45 H............. 030508, ref SDS 21 SM6M
120437 -          030215......... 46 H............. 030220, ref SDS 20 5E6L
120438 -          030106......... 37 H............. 030109, ref SDS 19 SM6M
120439 -          021202......... 41 H?............ 021204, ref SDS 18 SP5G
120440 -          021111......... 36 H?............ 021113, ref SDS 17 Y65I
120441 -          021023......... 33 H?............ 021023, ref SDS 16 SQ5I
120442 -          020930......... 33 H?..29........ 021002, ref SDS 15 SQ5I
120443 -          020917......... 36 H?............ 020924, ref SDS 14 SQ5I
120444 -          020717......... 59 H?............ 020726, ref SDS 13 YN5K
120445 -          020629......... 75 H ............ 020705, ref SDS 12 UX6I
120446 -          020608........  67 H ............ 020614, ref SDS 11 0001
120447 -          020603........ 108 H ............ 020607, ref SDS 10 X67F
120448 -          020511........ 117 H ............ 020603, ref SDS 9 PJ4J
120449 -          020419......... 81 H ............ 020430, ref SDS 8 7N5H
120450 -          020321......... 85 H ............ 020405, ref SDS 7 6T8K
120451 -
120452 -
120454 -  ..
1205 -
1206 -
1207 - Analysis
1208 -
120801 - CA 15-3 100 Cancer Marker Rises Again Signaling IBC Worsens
120802 - IBC Progressing Clinical Symptoms Rise Aligns with Rising CA 15-3
120803 -
120804 - Follow up ref SDS 58 GJ5M, ref SDS 53 GJ5M.
120805 -
120806 - On 050316 treatment was deferred again because white blood cell count
120807 - was much too low. ref SDS 60 0001  On 050324 the surgeon found
120808 - worsening IBC. ref SDS 61 YY7F
120810 -  ..
120811 - The doctor feels today that this record of worsening IBC symptoms,
120812 - discussed below, ref SDS 0 025H, aligns with CA 15-3 rising
120813 - substantially from 78 on 050214 to over 100 under the current
120814 - treatment plan using AC, initially prescribed for two (2) treatments
120815 - on 041230, ref SDS 48 XQ41, and later extended on 050311, ref SDS 58
120816 - J544, after plans to change treatment if CA 15-3 continues rising,
120817 - discussed with Millie in the hospital on 050214. ref SDS 55 W58T  On
120818 - 030710 the doctor indicated CA 15-3 above 80 signaled consideration to
120819 - change course. ref SDS 23 WS42
120820 -
120821 -     [On 050520 dramatic improvement CA 15-3 falls from 105 to 67 after
120822 -     2 cycles of treatment with Taxotere and capecitabine (Xeloda).
120823 -     ref SDS 72 GJ5M
120824 -
120825 -
120826 -
120827 -
120828 -
1209 -

SUBJECTS
CT Test Report Not Available for Meeting Today to Evaluate Distant M

1303 -
130401 -  ..
130402 - CT Scan Test Results Not Available
130403 -
130404 - Follow up ref SDS 58 NL4N, ref SDS 53 NL4N.
130405 -
130406 - Results were not available today for CT test on 050325, ref SDS 62
130407 - 0001, scheduled on 050311 to evaluate new cancer sores and rising CA
130408 - 15-3 cancer marker. ref SDS 58 NL4N
130410 -  ..
130411 - The Doctor called a telephone number to get a verbal report on test
130412 - results.  There was a message saying the report for Millie's test has
130413 - not yet been posted by the analyst.  Though the report was not
130414 - available, analysis of other diagnostics suggest advancing IBC
130415 - activity, ref SDS 0 025H, which does not register strongly in CT
130416 - testing.  There was nothing in the examination today that suggests
130417 - distant metastasis, consistent with prior CT test results, e.g., on
130418 - 041230. ref SDS 48 NL4N
130419 -
130420 -
130421 -
130422 -
130423 -
1305 -

SUBJECTS
MUGA Test on Heart for Continuing AC Chemotherapy Treatments Results

1603 -
160401 -  ..
160402 - MUGA Test Not Available Evaluate Heart Damage from AC Treatments
160403 -
160404 - Follow up ref SDS 64 0001, ref SDS 58 9Z4N,.
160405 -
160406 - The doctor advised that results of the MUGA test on 050328 have not
160407 - yet been reported for evaluating heart damage from continuing AC
160408 - treatments, ref SDS 64 0001, which was planned during the meeting on
160409 - 041230. ref SDS 48 XQ84,
160410 -
160411 -
160412 -
160413 -
160414 -
160415 -
160416 -
160417 -
1605 -

SUBJECTS
Pulmonary Emoboli Symptoms End Treatment with Coumadin Continue

2303 -
230401 -  ..
230402 - Pulmonary Emoboli Symptoms End Treatment with Coumadin Continue
230403 - Coumadin Treatment Continues for Pulmonary Emoboli after Symptoms End
230404 -
230405 - Follow up ref SDS 58 RZ4I, ref SDS 53 RZ4I.
230406 -
230407 - No discussion again during this meeting to carry out review based on
230408 - planning during the meeting on 050204 to assess Coumadin requirements
230409 - in a few months time. ref SDS 53 S34O
230411 -  ..
230412 - No symptoms pulmonary emboli, blood clots.
230413 -
230414 -
230415 -
230416 -
230417 -
2305 -

SUBJECTS
Arm Lumps Lymph Nodes Swelled Under Left Side No Examination Patient

2503 -
250401 -  ..
250402 - Lumps Under Arm Seems Unchanged
250403 -
250404 - Follow up ref SDS 58 MW8J, ref SDS 53 MW8J.
250405 -
250406 - There was no examination and no discussion of lump under the arm due
250407 - to focus on new problems in the left breast.
250408 -
250409 -
250410 -
250411 -
2505 -

SUBJECTS
Neck Lumps Lymph Nodes Left Side No Examination Patient Reports Favo

3003 -
300401 -  ..
300402 - Lumps in Neck No Evidence of Swelling Indicating Cancer Receded
300403 -
300404 - Follow up ref SDS 58 8R6M, ref SDS 53 8R6M.
300405 -
300406 - No examination of the neck, because of prior favorable examinations
300407 - and testing the past few months, illustrated by the report on 041104.
300408 - ref SDS 38 8R6M
300409 -
300410 -
300411 -
300412 -
3005 -

SUBJECTS
Wound Punch Biopsy Left Breast Healing Improves after 4 Treatments w

3703 -
370401 -  ..
370402 - Wound Biopsy Beginning to Heal Treatment with Adriamycin Cytoxan AC
370403 -
370404 - Follow up ref SDS 58 6T5G, ref SDS 53 6T5G.
370405 -
370406 - The doctor examined the left breast and noted slow, steady healing of
370407 - the punch biopsy wound since examination on 050311, and following the
370408 - 4th treatment of chemotherapy for IBC with AC on 050325. ref SDS 63
370409 - KR30
370411 -  ..
370412 - This aligns with the surgeon's comments on 050324 finding marked
370413 - improvement healing the biopsy wound, ref SDS 61 906K, since the
370414 - examination on 050107.
370415 -
370416 -
370417 -
370418 -
370419 -
370420 -
370421 -
3705 -

SUBJECTS
IBC Cancer Sores Blister Left Breast Redness IBC Spreads Slow Recove
IBC Worsens Cancer Sores Begin to Blister on Left Breast Redness IBC

4304 -
430501 -  ..
430502 - IBC May be Less Intense Hard to Remember Spread of Disease Not Good
430503 - Cancer Sores Left Breast Blistering IBC with AC Treatment Slow Improve
430504 - Blistering Sores Cancer Left Breast IBC Slow Improve with AC Treatment
430505 -
430506 - Follow up ref SDS 58 025H, ref SDS 53 025H.
430508 -  ..
430509 - Redness IBC Spreads Rising CA 15-3 Slow Progress AC Change Treatment
430511 -  ..
430512 - The doctor commented that red coloration from IBC inflammation seems
430513 - less intense today, but it is hard to remember after seeing so many
430514 - patients since the prior examination on 050311.  The spread of redness
430515 - above the breast, along with cancer sores observed is not good.  This
430516 - aligns the surgeon's examination a few days ago on 050324, ref SDS 61
430517 - YY7F  The doctor cited rising CA 15-3 cancer marker, now at 100,
430518 - indicates treatment is not achieving results, based on prior
430519 - experience reported by the doctor on 030710, ref SDS 23 WS42, and
430520 - discussed again today, per above. ref SDS 0 GJ5M
430522 -  ..
430523 - The doctor feels treatment should be changed, discussed below.
430524 - ref SDS 0 AW5G
430526 -      ..
430527 -     [On 050502 visual improvement sores and inflamation are receding,
430528 -     ref SDS 69 EO5J
430530 -      ..
430531 -     [On 050510 further improvement inflammation (redness) seems
430532 -     entirely gone, and softness has returned to the breast.
430533 -     ref SDS 70 EO5J
430535 -      ..
430536 -     [On 050520 dramatic improvement after 2 cycles of treatment with
430537 -     Taxotere and Xeloda. ref SDS 73 R19I
430538 -
430539 -
430540 -
430541 -
430542 -
4306 -

SUBJECTS
Management Standards Healthwise Handbook Communication Collaboration
Hectec Busy Being Busy Not Enough Time to Think Continual Bumbling I
Patient Organize Medical Record Organizational Memory Critical Facto
Surgery Examination on 050324 to Evaluate Readiness for Masectomy Pr

7006 -
700701 -  ..
700702 - Hectic Schedule Report on Surgeon Examination Pending Review
700703 - Examination by Surgeon Recommends Healing IBC Prior to Surgery
700704 -
700705 - Follow up ref SDS 58 XQ41, ref SDS 53 XQ41.
700706 -
700707 - The doctor asked about results of meeting with the surgeon on 050324
700708 - to consider a mastectomy for treating "pockets of resistance" to
700709 - chemotheapy? ref SDS 61 GK9M
700711 -  ..
700712 - Background on considerations for surgery in this case are summarized
700713 - on 041210, ref SDS 45 ZV5J, and case study to extend quality of life
700714 - by preventing disease from cascading out of control is reported on
700715 - 041230. ref SDS 48 XV7M
700717 -  ..
700718 - Millie asked about the surgeon's report to Oncology, planned in the
700719 - meeting on 050324? ref SDS 61 ER7F
700721 -  ..
700722 - The doctor said things have been hectic, similar to the report on
700723 - 020726, ref SDS 13 SQ5I, and, as a result, there has not been time for
700724 - the Oncology Department to collaborate with the surgeon in the manner
700725 - planned on 041230, ref SDS 48 UJ5M, nor to look for the Surgeon's
700726 - report on Millie's case, and make a review of the meeting last week in
700727 - order to prepare for the meeting today under Team Care practice,
700728 - discussed previously on 050311. ref SDS 58 PB6J
700729 -
700730 -     [On 050727 due diligence discussed with surgeon to collaborate and
700731 -     communicate through Team Care for leveraging experience with a
700732 -     Tumor Board and investigating among colleagues and experts for
700733 -     treating IBC, which is a rare disease for which experience is very
700734 -     limited among daily practioners. ref SDS 76 O85O
700736 -      ..
700737 -     [On 050824 Advice Nurse in Surgery Department expects surgeon
700738 -     applied Team Care practice to collaborate with a referral doctor
700739 -     in Kaiser's Oakland office by providing background and explaining
700740 -     patient history so that the referral doctor can be prepared to
700741 -     conduct a productive meeting with the patient. ref SDS 78 HX48
700743 -      ..
700744 -     [On 050826 referral doctor in Oakland was not familiar with Kaiser
700745 -     organizational memory on patient history; background submitted
700746 -     during the meeting was described as the only summary available, as
700747 -     helpful, but was too late for the doctor to be prepared, so the
700748 -     entire meeting was based on recollections of personal memory.
700749 -     ref SDS 79 BL8N
700751 -  ..
700752 - This aligns with reporting on 970910 that people do not have enough
700753 - time to think due to a hectic schedule. ref SDS 2 3479  Previously,
700754 - Kissinger noted that limited time reduces analysis, reviewed on
700755 - 940609. ref SDS 1 4238  Hurrying under duress of limited time was
700756 - cited in the study on 990912 explaining the high cost of medical
700757 - mistakes. ref SDS 5 0285
700759 -  ..
700760 - The doctor asked again today for patient impressions from meeting the
700761 - surgeon on 050324, repeating the process used during the meeting on
700762 - 050204, ref SDS 53 RD3M, to get results on the surgeon's prior
700763 - examination on 050107.
700765 -  ..
700766 - Millie related the surgeon's reluctance to perform surgery for a
700767 - masectomy on the left breast until disease is fully cleared from the
700768 - site, reported on 050324. ref SDS 61 WH5L
700769 -
700770 -     [On 050727 follow up examination by surgeon shows biopsy wound
700771 -     fully healed, and IBC has healed sufficiently for surgery after 4
700772 -     treatments with Taxotere and capecitabine. ref SDS 76 CK7N
700774 -      ..
700775 -     [On 050729 doctor asks about results of surgeon's examination on
700776 -     050727, and schedule for performing surgery pending due diligence
700777 -     on criteria. ref SDS 77 XQ41
700779 -  ..
700780 - The doctor asked about discussion of criteria for surgery, from
700781 - planning on 050311? ref SDS 58 PB4N
700783 -  ..
700784 - Millie recalled there was discussion with the surgeon on 050324 about
700785 - criteria for performing masectomy; details are hard to remember, and
700786 - are set out in the record of the meeting on 050324. ref SDS 61 OV5H
700788 -  ..
700789 - The doctor plans to talk with the surgeon on this.
700790 -
700791 -     [On 050401 Millie and Pam met with Doctor Choi who recommended
700792 -     against surgery at this time; there was no evident discussion on
700793 -     criteria that establish level of recovery where surgery can be
700794 -     performed. ref SDS 66 PPSU
700796 -      ..
700797 -     [On 050727 surgeon reported there have not yet been discussions
700798 -     with the primary care physician on Millie's case. ref SDS 76 OV5H
700799 -
700800 -
700801 -
700802 -
7009 -

SUBJECTS
Surgeon Experienced Mastectomy Procedures Best in Kaiser Walnut Cree

7203 -
720401 -  ..
720402 - Surgeon Most Experienced Performing Mastectomy Procedures
720403 -
720404 - Millie cited concerns by the surgeon on 050324 having limited
720405 - experience performing surgery for a masectomy on a patient with IBC,
720406 - and particularly, where the doctor proposes to treat "pockets of
720407 - resistance" to chemotherapy with surgery, ref SDS 61 QJ3Q, requested
720408 - for consideration by the doctor during the meeting on 050311.
720409 - ref SDS 58 PA4N
720411 -  ..
720412 - The doctor commented today that Millie is fortunate because the
720413 - surgeon who made the examination and consultation on 050324 is the
720414 - most experienced surgeon in the Walnut Creek, CA hospital and clinic.
720415 -
720416 -     [On 050401 Doctor Choi concurred with this assesment. ref SDS 66
720417 -     PPVP
720419 -      ..
720420 -     [On 050727 follow up examination by surgeon shows biopsy wound
720421 -     fully healed, and IBC has healed sufficiently for surgery after 4
720422 -     treatments with Taxotere and capecitabine. ref SDS 76 CK7N
720424 -      ..
720425 -     [On 050928 Doctor Smith commends surgeon's commitment to patient
720426 -     care, and strong feelings for Millie's case. ref SDS 81 258K
720427 -
720428 -
720429 -
720430 -
720431 -
720432 -
720433 -
720434 -
720435 -
7205 -

SUBJECTS
Adriamycin Cytoxan AC 2 Cycles Doctor Prescribes Additional Cycles a
Treatment Plan End Adriamycin Cytoxan AC after 6 Total Treatments Ch
Chemotherapy Not Effective New Blood Test Orderded Changed Treatment
Adriamycin Cytoxan AC Ended after 6 Total Treatments New Treatment P

8306 -
830701 -  ..
830702 - Adriamycin Cytoxan AC Treatment Stopped
830703 - Treatment Plan Change Chemotherapy from AC to Taxotere Capeticabine
830704 - Taxotere Capeticabine (Xeloda) Chemotherapy under New Treatment Plan
830705 -
830706 - Follow up ref SDS 58 J53N, ref SDS 48 XQ41.
830707 -
830708 - The doctor reviewed analysis on 050311, ref SDS 58 7B4F, which led to
830709 - planning that continued treatment with AC, rather than switch to
830710 - Taxol, Taxotere, Capacitabine, etc. ref SDS 58 J53N
830712 -  ..
830713 - The doctor cited difficulty maintaining a consistant level of medicine
830714 - in the patient's body, due to deferred treatments on 050316,
830715 - ref SDS 60 0001, and previously on 050225, ref SDS 56 407N  This
830716 - reduced concentration of AC chemotherapy may be causing slow response
830717 - to the current regimen begun on 050104, ref SDS 50 0001, to implement
830718 - planning on 041230, ref SDS 48 XQ41, and then amended on 050204,
830719 - adding two (2) additional treatments with AC. ref SDS 53 XQ41
830721 -  ..
830722 - Millie asked about changing treatment to improve results by switching
830723 - to a different chemotherapy regimen listed in planning on 041230 to
830724 - try Taxol, Taxotere, capeticabine, etc. ref SDS 48 Y37T
830726 -  ..
830727 - Since recovery is slow, and IBC may be worsening, found by the surgeon
830728 - on 050324, again by the doctor today, ref SDS 0 025H, and indicated by
830729 - CA 15-3 rising to 100, per above, ref SDS 0 GJ5M, the doctor proposed
830730 - the following change to try a new work plan...
830731 -
830732 -    a.  AC will be discontinued after 6 cycles today to prevent cancer
830733 -        from getting worse, under reasoning on 041230. ref SDS 48 XQ84
830734 -        This avoids further concern about impact of 6 AC treatments on
830735 -        the heart, reviewed on 050204. ref SDS 53 M46G  Results of the
830736 -        MUGA test are not available, but since CA 15-3, coloration and
830737 -        sores on the breast indicate that AC may not be effective
830738 -        enough to reach a point that permits mastectomy surgery, a
830739 -        change improves chances of recovery for the patient and
830740 -        prevents disease from cascading out of control, discussed by
830741 -        the doctor, also, on 041230. ref SDS 48 P19O
830742 -
830743 -            [On 050422 MUGA test report shows no evidence heart damage.
830744 -            ref SDS 68 UG4H
830746 -         ..
830747 -    b.  Taxotere and capecitabine (Xeloda) couplet will be tried,
830748 -        beginning in three (3) weeks on 050415.  This maintains current
830749 -        treatment schedule, but switches from AC to the new treatment
830750 -        recommended by Doctor Benze at UCSF in a 2nd opinion received
830751 -        on 041117, ref SDS 39 OU6S, and discussed with the doctor at
830752 -        Kaiser on 041130. ref SDS 40 5X4J  Today, the doctor scheduled
830753 -        four (4) cycles with Millie getting Taxotere every three weeks.
830754 -        In addition she will ingest two (2) pills of capecitabine
830755 -        (Xeloda) twice a day for two (2) weeks beginning the day of
830756 -        treatment with Taxotere.  She will then have a one week rest,
830757 -        before starting the next cycle of Taxotere on the 3rd week.
830758 -
830759 -            [On 050913 doctor objects that 2nd opinions delay
830760 -            mastectomy surgery for patient with secondary IBC, history
830761 -            of relapse, and pulmonary emboli. ref SDS 80 G44O
830763 -             ..
830764 -            [On 061208 doctor objects to multi-agent, couplets
830765 -            combining chemotherapy drug treatments. ref SDS 83 HS5O
830767 -         ..
830768 -        This implements review on 041230 citing advantage of taxaine
830769 -        for Millie's patient profile, ref SDS 48 2V85, and analysis of
830770 -        treatment plan, also, on 041230. ref SDS 48 D49F
830772 -         ..
830773 -        The goal is positive response that permits surgery, per visit
830774 -        with surgeon on 050324. ref SDS 61 WH5L
830775 -
830776 -            [On 050415 treatment begins with new chemotherapy protocol
830777 -            Taxotere and capecitiabine (Xeloda). ref SDS 67 407N
830778 -
830779 -            [On 050502 marked improvement after 2 weeks of treatment
830780 -            with Taxotere and capecitabine (Xeloda), IBC significantly
830781 -            subsides. ref SDS 69 EO5J
830783 -             ..
830784 -            [On 050510 further improvement inflammation (redness) seems
830785 -            entirely gone, and softness has returned to the breast.
830786 -            ref SDS 70 EO5J
830788 -             ..
830789 -            [On 050520 dramatic improvement after 2 cycles of treatment
830790 -            with Taxotere and capecitabine (Xeloda), ref SDS 72 025H,
830791 -            despite temporarily stopping treatments beginning on 050514
830792 -            due to severe side effects, ref SDS 71 RU9M; on 050520
830793 -            treatment dose for capecitabine (Xeloda) reduced to reduce
830794 -            side effects. ref SDS 72 NT3I
830796 -             ..
830797 -            [On 050610 recovery from IBC continues with reduced dose of
830798 -            capecitabine (Xeloda) beginning 4th cycle. ref SDS 74 025H
830800 -             ..
830801 -            [On 051007 PET scan test reports no evidence of local,
830802 -            regional, nor local cancer after 8 cycles of treatment with
830803 -            Taxotere and capecitabine. ref SDS 82 L66M
830804 -
830805 -
830807 -         ..
830808 -        Side Effects Peeling Blisters on Feet Hands
830809 -
830810 -        Doctor explained possible effects that hands and feet
830811 -        may show some redness.  The doctor advised that
830812 -        Millie will get a call from the pharmacist to
830813 -        schedule a meeting for review of all side effects and
830814 -        to prescribe medications that reduce problems due to
830815 -        side effects.
830816 -
830817 -            [On 050415 pharmacist met with Millie in the
830818 -            clinic while she was getting the first day of new
830819 -            chemotherapy treatments. ref SDS 67 7F8Q
830821 -             ..
830822 -            [On 050510 Millie experienced pain hands and
830823 -            feet. ref SDS 70 DX54
830825 -             ..
830826 -            [On 050520 dramatic improvement after 2 cycles of treatment
830827 -            with Taxotere and capecitabine (Xeloda), ref SDS 72 025H,
830828 -            despite temporarily stopping treatments beginning on 050514
830829 -            due to severe side effects, ref SDS 71 RU9M; on 050520
830830 -            treatment dose for capecitabine (Xeloda) reduced to reduce
830831 -            side effects. ref SDS 72 NT3I
830833 -             ..
830834 -            [On 050610 recovery from IBC continues with reduced dose of
830835 -            capecitabine (Xeloda). ref SDS 74 025H
830836 -
830837 -
830838 -
830839 -
830840 -
830841 -
830842 -
8309 -